Trial Profile
A feasibility combination study of S-1 and carboplatin in patients with interstitial pneumonia (IP) and advanced non small cell lung cancer (NSCLC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer; Pneumonia
- Focus Therapeutic Use
- 12 Dec 2015 New trial record